Prostate imaging-reporting and data system version 2: Beyond prostate cancer detection

Sung Yoon Park, Nam Hoon Cho, Dae Chul Jung, Young Taik Oh

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric magnetic resonance imaging. Since the first introduction of PI-RADSv2, researchers have validated its diagnostic performance in identifying csPCa, and these promising data have influenced biopsy and treatment schemes. However, in this article, we focused on the potential of PI-RADSv2 in relation to various aspects of PCa such as Gleason score, tumor volume, extraprostatic extension, lymph node metastasis, and postoperative biochemical recurrence, beyond prostate cancer detection.

Original languageEnglish
Pages (from-to)193-200
Number of pages8
JournalKorean journal of radiology
Volume19
Issue number2
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

Information Systems
Prostate
Prostatic Neoplasms
Neoplasm Grading
Tumor Burden
Lymph Nodes
Research Personnel
Magnetic Resonance Imaging
Neoplasm Metastasis
Biopsy
Recurrence

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Park, Sung Yoon ; Cho, Nam Hoon ; Jung, Dae Chul ; Oh, Young Taik. / Prostate imaging-reporting and data system version 2 : Beyond prostate cancer detection. In: Korean journal of radiology. 2018 ; Vol. 19, No. 2. pp. 193-200.
@article{10bbb5b1e6854f26b37d9e4c57c5d1aa,
title = "Prostate imaging-reporting and data system version 2: Beyond prostate cancer detection",
abstract = "The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric magnetic resonance imaging. Since the first introduction of PI-RADSv2, researchers have validated its diagnostic performance in identifying csPCa, and these promising data have influenced biopsy and treatment schemes. However, in this article, we focused on the potential of PI-RADSv2 in relation to various aspects of PCa such as Gleason score, tumor volume, extraprostatic extension, lymph node metastasis, and postoperative biochemical recurrence, beyond prostate cancer detection.",
author = "Park, {Sung Yoon} and Cho, {Nam Hoon} and Jung, {Dae Chul} and Oh, {Young Taik}",
year = "2018",
month = "3",
day = "1",
doi = "10.3348/kjr.2018.19.2.193",
language = "English",
volume = "19",
pages = "193--200",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "2",

}

Prostate imaging-reporting and data system version 2 : Beyond prostate cancer detection. / Park, Sung Yoon; Cho, Nam Hoon; Jung, Dae Chul; Oh, Young Taik.

In: Korean journal of radiology, Vol. 19, No. 2, 01.03.2018, p. 193-200.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prostate imaging-reporting and data system version 2

T2 - Beyond prostate cancer detection

AU - Park, Sung Yoon

AU - Cho, Nam Hoon

AU - Jung, Dae Chul

AU - Oh, Young Taik

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric magnetic resonance imaging. Since the first introduction of PI-RADSv2, researchers have validated its diagnostic performance in identifying csPCa, and these promising data have influenced biopsy and treatment schemes. However, in this article, we focused on the potential of PI-RADSv2 in relation to various aspects of PCa such as Gleason score, tumor volume, extraprostatic extension, lymph node metastasis, and postoperative biochemical recurrence, beyond prostate cancer detection.

AB - The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric magnetic resonance imaging. Since the first introduction of PI-RADSv2, researchers have validated its diagnostic performance in identifying csPCa, and these promising data have influenced biopsy and treatment schemes. However, in this article, we focused on the potential of PI-RADSv2 in relation to various aspects of PCa such as Gleason score, tumor volume, extraprostatic extension, lymph node metastasis, and postoperative biochemical recurrence, beyond prostate cancer detection.

UR - http://www.scopus.com/inward/record.url?scp=85042883099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042883099&partnerID=8YFLogxK

U2 - 10.3348/kjr.2018.19.2.193

DO - 10.3348/kjr.2018.19.2.193

M3 - Review article

C2 - 29520176

AN - SCOPUS:85042883099

VL - 19

SP - 193

EP - 200

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

SN - 1229-6929

IS - 2

ER -